Emese Bato

Emese Bato

Auto-generated profile, based on publicly available information

Emese Bato

Institute of Biophysics, HUN-REN Biological Research Centre, 6726 Szeged, Hungary; University of Szeged, 6726 Szeged, Hungary

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JVJudit P. Vigh
Judit P. Vigh
AKAnna E. Kocsis
Anna E. Kocsis
Ana Raquel Santa-MariaAna Raquel Santa-Maria
Ana Raquel Santa-Maria
Nóra KucsápszkyNóra Kucsápszky
Nóra Kucsápszky
EBEmese Bato
Emese Bato
Fruzsina WalterFruzsina Walter
Fruzsina Walter
For advanced biomedical research, complex, well-described human blood-brain barrier (BBB) models are crucial for studying central nervous system pathologies and brain targeting of nanotherapeutics. Our aim was to establish and characterize a complex lab-on-a-chip (LOC) system integrating a BBB model with neural organoids (NO). We optimized the conditions for BBB-NO models under static and dynamic circumstances. The combination of a human stem cell-derived BBB co-culture model with human midbrain organoids in a microfluidic LOC allowed the observation of BBB and neural tissue changes and the separate analysis of the barrier and brain units. The LOC design enabled phase contrast and fluorescent microscopy on the whole brain endothelial culture surface, barrier integrity and permeability measurements across the BBB model, and molecule passage into NOs. BBB-specific endothelial morphology, gene and protein expression, and good barrier integrity were demonstrated, corroborating the strength of the LOC engineering and cellular design. The transport of targeted nanoparticles across the BBB model followed by their entry to neural organoids validated the barrier integrity and transporter functionality of the dynamic integrated complex model. As a proof-of-concept experiment to confirm the translational value of the BBB-NO model integrated in the LOC device, we examined a clinically used hyperosmolar iodinated contrast agent, iopamidol, with confirmed neurological side effects. We corroborated that iopamidol induces transient BBB dysfunction and neural effects in the complex system, not only validating the complex dynamic BBB-NO model but also pointing to the necessity to study BBB changes together with NO functions.